Kevin Horgan

11.3k total citations · 4 hit papers
63 papers, 9.1k citations indexed

About

Kevin Horgan is a scholar working on Surgery, Immunology and Physiology. According to data from OpenAlex, Kevin Horgan has authored 63 papers receiving a total of 9.1k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Surgery, 14 papers in Immunology and 13 papers in Physiology. Recurrent topics in Kevin Horgan's work include Nausea and vomiting management (25 papers), Anesthesia and Pain Management (18 papers) and Cell Adhesion Molecules Research (11 papers). Kevin Horgan is often cited by papers focused on Nausea and vomiting management (25 papers), Anesthesia and Pain Management (18 papers) and Cell Adhesion Molecules Research (11 papers). Kevin Horgan collaborates with scholars based in United States, Canada and Netherlands. Kevin Horgan's co-authors include Yoji Shimizu, Stephen Shaw, G A van Seventer, Gijs A. van Seventer, Judith K. Evans, Robert S. Bresalier, Hui Quan, Bettina Oxenius, Ángel Lanas and Robert S. Sandler and has published in prestigious journals such as Nature, New England Journal of Medicine and The Journal of Experimental Medicine.

In The Last Decade

Kevin Horgan

61 papers receiving 8.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial

2005 1.9k citations Robert S. Bresalier, Robert S. Sandler et al. New England Journal of Medicine profile →
The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells.

1990 698 citations G A van Seventer, Yoji Shimizu et al. The Journal of Immunology profile →
The Oral Neurokinin-1 Antagonist Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients Receiving High-Dose Cisplatin—The Aprepitant Protocol 052 Study Group

2003 593 citations Paul J. Hesketh, Steven M. Grunberg et al. profile →
Regulated expression and binding of three VLA (β1) integrin receptors on T cells

1990 568 citations Yoji Shimizu, Gijs A. van Seventer et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kevin Horgan United States	34	3.2k	2.3k	2.2k	1.6k	1.5k	63	9.1k
Paolo Gresele Italy	58	1.7k 0.5×	1.0k 0.5×	529 0.2×	863 0.5×	1.0k 0.7×	311	10.1k
Uwe Schönbeck United States	45	2.2k 0.7×	5.1k 2.2×	1.8k 0.8×	714 0.4×	675 0.4×	56	11.5k
G. Schernthaner Austria	45	1.4k 0.4×	1.4k 0.6×	510 0.2×	431 0.3×	1.1k 0.7×	251	6.4k
P A Bacon United Kingdom	47	970 0.3×	2.7k 1.2×	492 0.2×	463 0.3×	2.0k 1.3×	194	11.4k
Elliot S. Barnathan United States	42	1.4k 0.4×	1.2k 0.5×	568 0.3×	350 0.2×	1.9k 1.3×	106	8.0k
Linda K. Curtiss United States	67	5.1k 1.6×	5.8k 2.5×	832 0.4×	381 0.2×	1.1k 0.7×	190	15.0k
Korbinian Brand Germany	42	1.1k 0.4×	2.3k 1.0×	593 0.3×	663 0.4×	329 0.2×	112	7.5k
Anthony J. Valente United States	55	1.5k 0.5×	3.2k 1.4×	804 0.4×	288 0.2×	881 0.6×	122	8.9k
George F. Schreiner United States	56	1.2k 0.4×	1.5k 0.6×	393 0.2×	417 0.3×	1.2k 0.8×	139	11.3k
Rolf A.K. Stahl Germany	59	865 0.3×	3.4k 1.5×	350 0.2×	630 0.4×	1.4k 0.9×	257	12.2k

Countries citing papers authored by Kevin Horgan

Since Specialization

Citations

This map shows the geographic impact of Kevin Horgan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Horgan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Horgan more than expected).

Fields of papers citing papers by Kevin Horgan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Horgan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Horgan. The network helps show where Kevin Horgan may publish in the future.

Co-authorship network of co-authors of Kevin Horgan

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Horgan. A scholar is included among the top collaborators of Kevin Horgan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Horgan. Kevin Horgan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Martin, Paul J., Terry Furlong, Scott D. Rowley, et al.. (2011). Evaluation of Oral Beclomethasone Dipropionate for Prevention of Acute Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 18(6). 922–929. 16 indexed citations

Sandborn, William J., Paul Rutgeerts, Brian G. Feagan, et al.. (2009). Colectomy Rate Comparison After Treatment of Ulcerative Colitis With Placebo or Infliximab. Gastroenterology. 137(4). 1250–1260. 356 indexed citations

Gan, Tong J., Christian C. Apfel, Anthony L. Kovac, et al.. (2007). A Randomized, Double-Blind Comparison of the NK1 Antagonist, Aprepitant, Versus Ondansetron for the Prevention of Postoperative Nausea and Vomiting. Anesthesia & Analgesia. 104(5). 1082–1089. 128 indexed citations

Baron, John A., Robert S. Sandler, Robert S. Bresalier, et al.. (2006). A Randomized Trial of Rofecoxib for the Chemoprevention of Colorectal Adenomas. Gastroenterology. 131(6). 1674–1682. 325 indexed citations

Bresalier, Robert S., Robert S. Sandler, Hui Quan, et al.. (2005). Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial. New England Journal of Medicine. 352(11). 1092–1102. 1855 indexed citations breakdown →

Herrstedt, Jørn, Hyman B. Muss, David Warr, et al.. (2005). Efficacy and tolerability of aprepitant for the prevention of chemotherapy‐induced nausea and emesis over multiple cycles of moderately emetogenic chemotherapy. Cancer. 104(7). 1548–1555. 96 indexed citations

deWit, R, Bernardo L. Rapoport, A. Carides, et al.. (2004). The oral NK1 antagonist, aprepitant, given with standard antiemetics provides protection against nausea and vomiting over multiple cycles of cisplatin-based chemotherapya combined analysis of two randomised, placebo-controlled phase III clinical trials. European Journal of Cancer. 40(3). 403–410. 11 indexed citations

Horgan, Kevin, Steven M. Grunberg, Paul J. Hesketh, et al.. (2003). 945 Analysis of pooled data from two Phase III studies of the NK-1 antagonist aprepitant to assess relationships between the incidence and control of cisplatin-induced acute vomiting and delayed vomiting. European Journal of Cancer Supplements. 1(5). S284–S285. 5 indexed citations

Horgan, Kevin, Kevin J. Petty, Anup Majumdar, Scott A. Reines, & Judith K. Evans. (2003). Treatment Options for Chemotherapy-Induced Nausea and Vomiting. 2(5). 391–392. 1 indexed citations

10.

Carides, Alexandra D., et al.. (2003). Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy‐induced nausea and vomiting. Cancer. 97(12). 3090–3098. 459 indexed citations

11.

Hesketh, Paul J., Simon Van Belle, Matti Aapro, et al.. (2003). Differential involvement of neurotransmitters through the time course of cisplatin-induced emesis as revealed by therapy with specific receptor antagonists. European Journal of Cancer. 39(8). 1074–1080. 208 indexed citations

12.

Fuss, Ivan J., Warren Strober, Brenda A. Cuccherini, et al.. (1998). Intestinal lymphangiectasia, a disease characterized by selective loss of naive CD45RA+ lymphocytes into the gastrointestinal tract. European Journal of Immunology. 28(12). 4275–4285. 48 indexed citations

13.

Horgan, Kevin, Yoshiya Tanaka, Gale E. Ginther Luce, et al.. (1994). CD45RB expression defines two interconvertible subsets of human CD4⁺ T cells with memory function. European Journal of Immunology. 24(5). 1240–1243. 21 indexed citations

14.

Schweighoffer, Tamás, Yoichiro Tanaka, Mark Tidswell, et al.. (1993). Selective expression of integrin alpha 4 beta 7 on a subset of human CD4+ memory T cells with Hallmarks of gut-trophism.. The Journal of Immunology. 151(2). 717–729. 230 indexed citations

15.

Horgan, Kevin, Yoshiya Tanaka, & Stephen Shaw. (1992). Postthymic Differentiation of CD4 T Lymphocytes: Naive Versus Memory Subsets and Further Specialization among Memory Cells (Part 1 of 2). Chemical immunology/Fortschritte der Allergielehre/Progress in allergy/Chemical immunology and allergy. 54. 72–87. 15 indexed citations

16.

Tanaka, Yoshiya, Steven Μ. Albelda, Kevin Horgan, et al.. (1992). CD31 expressed on distinctive T cell subsets is a preferential amplifier of beta 1 integrin-mediated adhesion.. The Journal of Experimental Medicine. 176(1). 245–253. 329 indexed citations

17.

Horgan, Kevin, Gale E. Ginther Luce, Yoichiro Tanaka, et al.. (1992). Differential expression of VLA-alpha 4 and VLA-beta 1 discriminates multiple subsets of CD4+CD45R0+ "memory" T cells. The Journal of Immunology. 149(12). 4082–4087. 39 indexed citations

18.

Shimizu, Yoji, G A van Seventer, E Ennis, et al.. (1992). Crosslinking of the T cell-specific accessory molecules CD7 and CD28 modulates T cell adhesion.. The Journal of Experimental Medicine. 175(2). 577–582. 166 indexed citations

19.

Shimizu, Yoji, Walter Newman, T. Venkat Gopal, et al.. (1991). Four molecular pathways of T cell adhesion to endothelial cells. The Journal of Cell Biology. 113(5). 2 indexed citations

20.

Seventer, G A van, Yoji Shimizu, Kevin Horgan, & Steve Shaw. (1990). The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells.. The Journal of Immunology. 144(12). 4579–4586. 698 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact